Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sara Labiano

Showing results (31-40 of 44) with videos related to

Pageof 5
Sort By:
Cancer Research|August 24, 2016
Abscopal Effects of Radiotherapy Are Enhanced by Combined Immunostimulatory mAbs and Are Dependent on CD8 T Cells and CrossprimingMaría E Rodriguez-Ruiz, Inmaculada Rodriguez, Saray Garasa, et al.
Cancer Research|June 27, 2015
Nivolumab and Urelumab Enhance Antitumor Activity of Human T Lymphocytes Engrafted in Rag2-/-IL2Rγnull Immunodeficient MiceMiguel F Sanmamed, Inmaculada Rodriguez, Kurt A Schalper, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 10, 2016
Tumor-Produced Interleukin-8 Attracts Human Myeloid-Derived Suppressor Cells and Elicits Extrusion of Neutrophil Extracellular Traps (NETs)Carlos Alfaro, Alvaro Teijeira, Carmen Oñate, et al.
Journal for Immunotherapy of Cancer|July 20, 2021
CD137 and PD-L1 targeting with immunovirotherapy induces a potent and durable antitumor immune response in glioblastoma modelsMontserrat Puigdelloses, Marc Garcia-Moure, Sara Labiano, et al.
Molecular Therapy Oncolytics|August 11, 2022
Galectin-3 inhibition boosts the therapeutic efficacy of Semliki Forest virus in pediatric osteosarcomaGuillermo Herrador-Cañete, Marta Zalacain, Sara Labiano, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 30, 2020
Delta-24-RGD, an Oncolytic Adenovirus, Increases Survival and Promotes Proinflammatory Immune Landscape Remodeling in Models of AT/RT and CNS-PNETMarc Garcia-Moure, Marisol Gonzalez-Huarriz, Sara Labiano, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 27, 2021
Fibroblast Activation Protein α-Targeted CD40 Agonism Abrogates Systemic Toxicity and Enables Administration of High Doses to Induce Effective Antitumor ImmunityEva Sum, Moritz Rapp, Philipp Fröbel, et al.
Cancer Cell|November 26, 2019
Intratumor Adoptive Transfer of IL-12 mRNA Transiently Engineered Antitumor CD8<sup>+</sup> T CellsIñaki Etxeberria, Elixabet Bolaños, Jose I Quetglas, et al.
JCI Insight|April 8, 2022
Exploiting 4-1BB immune checkpoint to enhance the efficacy of oncolytic virotherapy for diffuse intrinsic pontine gliomasVirginia Laspidea, Montserrat Puigdelloses, Sara Labiano, et al.
Cell Reports. Medicine|June 27, 2025
Targeting the CD40 costimulatory receptor to improve virotherapy efficacy in diffuse midline gliomasSara Labiano, Javier Marco-Sanz, Iker Ausejo-Mauleon, et al.
Pageof 5

Showing results (31-40 of 44) with videos related to

Sort By:
Pageof 5
Cancer Research|August 24, 2016
Abscopal Effects of Radiotherapy Are Enhanced by Combined Immunostimulatory mAbs and Are Dependent on CD8 T Cells and CrossprimingMaría E Rodriguez-Ruiz, Inmaculada Rodriguez, Saray Garasa, et al.
Cancer Research|June 27, 2015
Nivolumab and Urelumab Enhance Antitumor Activity of Human T Lymphocytes Engrafted in Rag2-/-IL2Rγnull Immunodeficient MiceMiguel F Sanmamed, Inmaculada Rodriguez, Kurt A Schalper, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 10, 2016
Tumor-Produced Interleukin-8 Attracts Human Myeloid-Derived Suppressor Cells and Elicits Extrusion of Neutrophil Extracellular Traps (NETs)Carlos Alfaro, Alvaro Teijeira, Carmen Oñate, et al.
Journal for Immunotherapy of Cancer|July 20, 2021
CD137 and PD-L1 targeting with immunovirotherapy induces a potent and durable antitumor immune response in glioblastoma modelsMontserrat Puigdelloses, Marc Garcia-Moure, Sara Labiano, et al.
Molecular Therapy Oncolytics|August 11, 2022
Galectin-3 inhibition boosts the therapeutic efficacy of Semliki Forest virus in pediatric osteosarcomaGuillermo Herrador-Cañete, Marta Zalacain, Sara Labiano, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 30, 2020
Delta-24-RGD, an Oncolytic Adenovirus, Increases Survival and Promotes Proinflammatory Immune Landscape Remodeling in Models of AT/RT and CNS-PNETMarc Garcia-Moure, Marisol Gonzalez-Huarriz, Sara Labiano, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 27, 2021
Fibroblast Activation Protein α-Targeted CD40 Agonism Abrogates Systemic Toxicity and Enables Administration of High Doses to Induce Effective Antitumor ImmunityEva Sum, Moritz Rapp, Philipp Fröbel, et al.
Cancer Cell|November 26, 2019
Intratumor Adoptive Transfer of IL-12 mRNA Transiently Engineered Antitumor CD8<sup>+</sup> T CellsIñaki Etxeberria, Elixabet Bolaños, Jose I Quetglas, et al.
JCI Insight|April 8, 2022
Exploiting 4-1BB immune checkpoint to enhance the efficacy of oncolytic virotherapy for diffuse intrinsic pontine gliomasVirginia Laspidea, Montserrat Puigdelloses, Sara Labiano, et al.
Cell Reports. Medicine|June 27, 2025
Targeting the CD40 costimulatory receptor to improve virotherapy efficacy in diffuse midline gliomasSara Labiano, Javier Marco-Sanz, Iker Ausejo-Mauleon, et al.
Pageof 5